Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05218083 · ClinicalTrials.gov registry record · NA

REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19

A NA study of COVID-19 and Critical Illness, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
5
Study locations

NCT05218083 is a NA study of COVID-19 and Critical Illness that is actively recruiting participants, run by Duke University. The registered enrollment target is 120 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05218083, a NA study of COVID-19 and Critical Illness, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
5
Study locations

Study Summary

Multicenter, prospective, randomized controlled trial providing mobile health supported physical rehabilitation to 120 patients who have been critically ill with COVID-19 and who complete at least one exercise session.

Interventions

  • BEHAVIORAL REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT)

Study Locations (5)

Alabama

  • University of Alabama at Birmingham - Birmingham

Kentucky

  • University of Kentucky - Lexington

North Carolina

  • Duke University Health System - Durham

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2023-02-23
Est. Completion 2026-11-01
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05218083

The ClinicalTrials.gov registry entry for NCT05218083 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT) is the first listed.

NCT05218083 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Kentucky, North Carolina.

Frequently Asked Questions

What is clinical trial NCT05218083 about?

NCT05218083 is a clinical study titled "REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program With High Intensity Interval Training for COVID-19". Multicenter, prospective, randomized controlled trial providing mobile health supported physical rehabilitation to 120 patients who have been critically ill with COVID-19 and who complete at least one exercise session.

What is the current status of trial NCT05218083?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-02-23. Estimated completion is 2026-11-01.

What conditions does trial NCT05218083 study?

This clinical trial studies the following conditions: COVID-19, Critical Illness, ICU Acquired Weakness, Cardiorespiratory Fitness, PICS.

What interventions are being tested in trial NCT05218083?

The interventions under investigation include: REmotely monitored, Mobile health supported Multidomain Rehabilitation Program with High Intensity Interval Training (REMM-HIIT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05218083?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05218083 being conducted?

This trial has 5 study locations across Alabama, Kentucky, North Carolina, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.